BROWN BROTHERS HARRIMAN & CO

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 14661 NEW YORK, NY

Position in TAK

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$149,607

+$23,449 QoQ

Shares Held

9,333

+37.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#237

of 375 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BROWN BROTHERS HARRIMAN & CO holds $96,941,137 across 13 Drug Manufacturers - Specialty & Generic names. TAK ranks #4 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,332,672	$95,765,809
2	VTRS	Viatris Inc	50,553	$802,781
3	HLN	Haleon plc	16,242	$151,537
4	TAK	Takeda Pharmaceutical Co Ltd This page	9,333	$149,607
5	UTHR	UNITED THERAPEUTICS Corp	40	$21,673
6	RDY	Dr Reddys Laboratories Ltd	1,000	$14,490
7	TEVA	Teva Pharmaceutical Industries Ltd	384	$13,009
8	SUPN	Supernus Pharmaceuticals, Inc.	187	$8,697

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$149,607	9,333	+37.0%	Shares	Sole	2026-08-12
2026-03-31	$126,158	6,812	+646.9%	Shares	Sole	2026-05-14
2025-12-31	$14,218	912	+3277.8%	Shares	Sole	2026-02-12
2025-09-30	$395	27	-91.4%	Shares	Sole	2025-11-13
2025-06-30	$4,838	313	-75.4%	Shares	Sole	2025-08-11
2022-09-30	$16,484	1,271	+29.0%	Shares	Sole	2022-11-14
2022-06-30	$13,829	985	-86.5%	Shares	Sole	2022-08-11
2022-03-31	$104,765	7,316	+381.9%	Shares	Sole	2022-05-13
2021-06-30	$25,547	1,518	+49.6%	Shares	Sole	2021-08-13
2021-03-31	$18,533	1,015	-10.8%	Shares	Sole	2021-05-13
2020-12-31	$20,711	1,138	0.0%	Shares	Sole	2021-02-16
2020-09-30	$20,301	1,138	0.0%	Shares	Sole	2020-11-16
2020-06-30	$20,404	1,138	-8.7%	Shares	Sole	2020-08-13
2020-03-31	$18,929	1,247	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.